Last reviewed · How we verify
BAY60-4552 — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
BAY60-4552 (BAY60-4552) — Bayer.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| BAY60-4552 TARGET | BAY60-4552 | Bayer | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- BAY60-4552 CI watch — RSS
- BAY60-4552 CI watch — Atom
- BAY60-4552 CI watch — JSON
- BAY60-4552 alone — RSS
Cite this brief
Drug Landscape (2026). BAY60-4552 — Competitive Intelligence Brief. https://druglandscape.com/ci/bay60-4552. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab